Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Apr 16 2026

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-apr-16-2026-3

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Methotrexate Injection USP".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases